InsidersTradesSigma
FARMACOSMO SPA Stock: price and management transactions · Italy · Consob
Follow the FARMACOSMO SPA share price and the full management transaction log of the company, a listed equity based in Italy. Shares trade on IT IT, under the supervision of Consob. Operating in the Health Care sector, FARMACOSMO SPA has published 6 public disclosures. Market capitalisation: €19.4m. The latest transaction was disclosed on 24 June 2026 (Purchase). Among the most active insiders: Anonymous (PDMR). All data is accessible without an account.
6
Insider Decl.
0
Thresholds
€249
6 ops.
Buy Volume
·
0 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 24,970 of 25,899 companies
13.3
score / 100
Value12
Quality14
FCF yld-11%
Earn yld-23%
EV/EBITDA·
ROE-57%
Gross mgn27%
Net mgn-8.0%
Debt/EBITDA21.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 24 June 2026
Declarations6 total
100 shares@ €0.520.0004% mcap34.3% of flowShareCONSOB:186107
Ideal exit: 15 Mar 2027 (T+270)
100 shares@ €0.410.0003% mcap27.1% of flowShareCONSOB:185991
Ideal exit: 13 Mar 2027 (T+270)
150 shares@ €0.390.0004% mcap38.6% of flowShareCONSOB:185821
Ideal exit: 9 Mar 2027 (T+270)
35 shares@ €0.600.0001% mcap100.0% of flowShareCONSOB:177543
Ideal exit: 2 Nov 2026 (T+270)
35 shares@ €0.600.0001% mcap27.4% of flowShareCONSOB:177529
Ideal exit: 2 Nov 2026 (T+270)
91 shares@ €0.6120.0004% mcap72.6% of flowShareCONSOB:177282
Ideal exit: 27 Oct 2026 (T+270)
6 of 6 declarations
About FARMACOSMO SPA
FARMACOSMO SPA is an Italian company specializing in the healthcare and pharmaceutical sector. It is listed on the XMIL market.